European Innovation Council

Alesi Surgical Ltd. is a company based in Cardiff, United Kingdom, specializing in the development and commercialization of laparoscopic surgical smoke handling systems. Founded in 2009 as a spin-out from the Welsh Institute for Minimal Access Therapy, Alesi Surgical focuses on creating products that enhance the safety, efficiency, and outcomes of surgical procedures. Its innovative tools are portable and suitable for both laparoscopic and robot-assisted surgeries, utilizing electrostatic precipitation technology to eliminate surgical smoke and maintain a clear visual field during operations. The company distributes its products to hospitals across Europe, the Middle East, New Zealand, and Australia, leveraging its access to experienced surgeons and surgical trainers to identify challenges in surgical procedures and design effective solutions.

CYTO365 manufactures RondelO multi inlet stopcocks, designed to integrate into IV-sets to prevent drug incompatibility due to parallel infusion.

Novus Diagnostics develops a point-of-care diagnostic system for infectious diseases, including a sample-to-answer sepsis platform that rapidly detects and classifies pathogens in whole blood. The device provides automated pathogen identification within minutes from a blood sample, allowing healthcare providers to diagnose sepsis-related infections and initiate timely, cost-effective treatment.

CYTO365 manufactures RondelO multi inlet stopcocks, designed to integrate into IV-sets to prevent drug incompatibility due to parallel infusion.

ADVITOS GmbH is a Munich-based company that specializes in the design, development, and marketing of extracorporeal multiple organ support therapy products for hospitals in Germany. Founded in 2004, the company offers an innovative treatment method known as ADVanced organ support, which utilizes albumin dialysis to facilitate the removal of various toxins from the liver, lungs, and kidneys. This method enables the elimination of CO2, hepatic toxins, and both water-soluble and protein-bound nephrotoxins, while also addressing metabolic and respiratory acidosis. The ADVOS system operates using standard dialysis accesses and flow rates, distinguishing itself by not requiring gas exchangers for CO2 removal.

Novus Diagnostics develops a point-of-care diagnostic system for infectious diseases, including a sample-to-answer sepsis platform that rapidly detects and classifies pathogens in whole blood. The device provides automated pathogen identification within minutes from a blood sample, allowing healthcare providers to diagnose sepsis-related infections and initiate timely, cost-effective treatment.

ADVITOS GmbH is a Munich-based company that specializes in the design, development, and marketing of extracorporeal multiple organ support therapy products for hospitals in Germany. Founded in 2004, the company offers an innovative treatment method known as ADVanced organ support, which utilizes albumin dialysis to facilitate the removal of various toxins from the liver, lungs, and kidneys. This method enables the elimination of CO2, hepatic toxins, and both water-soluble and protein-bound nephrotoxins, while also addressing metabolic and respiratory acidosis. The ADVOS system operates using standard dialysis accesses and flow rates, distinguishing itself by not requiring gas exchangers for CO2 removal.

Weber Hospital Systems is a company that specializes in developing solutions to help minimize healthcare-associated infections (HAIs) in hospitals. By developing innovative solutions to help reduce the risk of HAIs, Weber Hospital Systems is likely to play an important role in improving patient outcomes and overall hospital safety. Their solutions include a range of products such as disinfectant systems, air filtration systems, and surface coatings that are designed to eliminate or reduce the presence of harmful pathogens in the hospital environment. One of the company's flagship products is the Weber Mediclean System, a fully automated disinfection system that uses UV-C light to kill bacteria and viruses on hospital surfaces. This system is designed to be fast and efficient, eliminating up to 99.99% of bacteria and viruses within a matter of minutes. In addition to their disinfection systems, Weber Hospital Systems also offers air filtration systems that use advanced HEPA filtration technology to remove harmful particles and pathogens from the air. Their surface coatings are designed to create a barrier that prevents the growth of bacteria and viruses on hospital surfaces, providing an additional layer of protection against HAIs.

Weber Hospital Systems is a company that specializes in developing solutions to help minimize healthcare-associated infections (HAIs) in hospitals. By developing innovative solutions to help reduce the risk of HAIs, Weber Hospital Systems is likely to play an important role in improving patient outcomes and overall hospital safety. Their solutions include a range of products such as disinfectant systems, air filtration systems, and surface coatings that are designed to eliminate or reduce the presence of harmful pathogens in the hospital environment. One of the company's flagship products is the Weber Mediclean System, a fully automated disinfection system that uses UV-C light to kill bacteria and viruses on hospital surfaces. This system is designed to be fast and efficient, eliminating up to 99.99% of bacteria and viruses within a matter of minutes. In addition to their disinfection systems, Weber Hospital Systems also offers air filtration systems that use advanced HEPA filtration technology to remove harmful particles and pathogens from the air. Their surface coatings are designed to create a barrier that prevents the growth of bacteria and viruses on hospital surfaces, providing an additional layer of protection against HAIs.